156 related articles for article (PubMed ID: 28420850)
1. Alert Regarding Cisplatin-induced Severe Adverse Events in Cancer Patients with Xeroderma Pigmentosum.
Sumiyoshi M; Soda H; Sadanaga N; Taniguchi H; Ikeda T; Maruta H; Dotsu Y; Ogawara D; Fukuda Y; Mukae H
Intern Med; 2017; 56(8):979-982. PubMed ID: 28420850
[TBL] [Abstract][Full Text] [Related]
2. Severe cisplatin-induced renal toxicity in a patient with xeroderma pigmentosum.
Gilbar PJ; Pokharel K
J Oncol Pharm Pract; 2022 Mar; 28(2):466-470. PubMed ID: 34647821
[TBL] [Abstract][Full Text] [Related]
3. Use of host cell reactivation of cisplatin-treated adenovirus 5 in human cell lines to detect repair of drug-treated DNA.
Maynard KR; Hosking LK; Hill BT
Chem Biol Interact; 1989; 71(4):353-65. PubMed ID: 2582540
[TBL] [Abstract][Full Text] [Related]
4. Unusual intraoral cancer with unexpected outcome in a patient with xeroderma pigmentosum: An alert for antineoplastic treatment.
Carneiro MC; Kimura TC; Tolentino ES; Pieralisi N; Veltrini VC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Jan; 129(1):e1-e11. PubMed ID: 31706804
[TBL] [Abstract][Full Text] [Related]
5. DNA cross-linked by cisplatin: a new probe for the DNA repair defect in xeroderma pigmentosum.
Chu G; Berg P
Mol Biol Med; 1987 Oct; 4(5):277-90. PubMed ID: 3695939
[TBL] [Abstract][Full Text] [Related]
6. Restoration of proliferating cell nuclear antigen (PCNA) complex formation in xeroderma pigmentosum group A cells following cis-diamminedichloroplatinum (II)-treatment by cell fusion with normal cells.
Miura M; Domon M; Sasaki T; Kondo S; Takasaki Y
J Cell Physiol; 1992 Sep; 152(3):639-45. PubMed ID: 1354671
[TBL] [Abstract][Full Text] [Related]
7. A new anticancer platinum compound, (-)-(R)-2-aminomethyl-pyrrolidine(1,1-cyclobutanedicarboxylato) platinum(II): DNA interstrand crosslinking, repair and lethal effects in normal human, Fanconi's anaemia and xeroderma pigmentosum cells.
Fujiwara Y; Nakamura M; Yokoo S
Br J Cancer; 1993 Jun; 67(6):1285-92. PubMed ID: 8512813
[TBL] [Abstract][Full Text] [Related]
8. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.
Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G
Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642
[TBL] [Abstract][Full Text] [Related]
9. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
[TBL] [Abstract][Full Text] [Related]
10. Xeroderma pigmentosum variant with multisystem involvement.
Hessel A; Siegle RJ; Mitchell DL; Cleaver JE
Arch Dermatol; 1992 Sep; 128(9):1233-7. PubMed ID: 1519938
[TBL] [Abstract][Full Text] [Related]
11. Enzyme defects in xeroderma pigmentosum.
Akiba H; Kato T; Seiji M
J Dermatol; 1976 Aug; 3(4):163-70. PubMed ID: 15633972
[TBL] [Abstract][Full Text] [Related]
12. A role for polymerase eta in the cellular tolerance to cisplatin-induced damage.
Albertella MR; Green CM; Lehmann AR; O'Connor MJ
Cancer Res; 2005 Nov; 65(21):9799-806. PubMed ID: 16267001
[TBL] [Abstract][Full Text] [Related]
13. DNA repair protects against cutaneous and internal neoplasia: evidence from xeroderma pigmentosum.
Kraemer KH; Lee MM; Scotto J
Carcinogenesis; 1984 Apr; 5(4):511-4. PubMed ID: 6705149
[TBL] [Abstract][Full Text] [Related]
14. Cockayne syndrome and xeroderma pigmentosum.
Rapin I; Lindenbaum Y; Dickson DW; Kraemer KH; Robbins JH
Neurology; 2000 Nov; 55(10):1442-9. PubMed ID: 11185579
[TBL] [Abstract][Full Text] [Related]
15. DNA repair and ultraviolet mutagenesis in cells from a new patient with xeroderma pigmentosum group G and cockayne syndrome resemble xeroderma pigmentosum cells.
Moriwaki S; Stefanini M; Lehmann AR; Hoeijmakers JH; Robbins JH; Rapin I; Botta E; Tanganelli B; Vermeulen W; Broughton BC; Kraemer KH
J Invest Dermatol; 1996 Oct; 107(4):647-53. PubMed ID: 8823375
[TBL] [Abstract][Full Text] [Related]
16. Transcription-coupled nucleotide excision repair as a determinant of cisplatin sensitivity of human cells.
Furuta T; Ueda T; Aune G; Sarasin A; Kraemer KH; Pommier Y
Cancer Res; 2002 Sep; 62(17):4899-902. PubMed ID: 12208738
[TBL] [Abstract][Full Text] [Related]
17. Defective DNA repair replication in xeroderma pigmentosum fibroblasts and DNA repair of somatic cell hybrids after UV irradiation.
Akiba H; Kato T; Nakano H; Seiji M
Tohoku J Exp Med; 1975 Sep; 117(1):1-13. PubMed ID: 1188925
[TBL] [Abstract][Full Text] [Related]
18. Xeroderma pigmentosum.
Norgauer J; Idzko M; Panther E; Hellstern O; Herouy Y
Eur J Dermatol; 2003; 13(1):4-9. PubMed ID: 12609773
[TBL] [Abstract][Full Text] [Related]
19. Clinical and molecular epidemiological study of xeroderma pigmentosum in China: A case series of 19 patients.
Zhou EY; Wang H; Lin Z; Xu G; Ma Z; Zhao J; Feng C; Duo L; Yin J; Yang Y
J Dermatol; 2017 Jan; 44(1):71-75. PubMed ID: 27607234
[TBL] [Abstract][Full Text] [Related]
20. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F
J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
